Sorry - There were no pages found that contain that search phrase.
 |
|
|
|
|
|
Treatment |
|
Location |
|
Last Updated |
|
|
|
Details |
|
A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Palo Alto, CA USA |
|
05/09/2008 |
|
|
|
|
|
Details |
|
A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
San Francisco, CA USA |
|
05/09/2008 |
|
|
|
Details |
|
A Phase II Study of Bevacizumab (Avastin) Plus Temodar and Tarceva After Radiation Therapy and Temodar in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma Who Are Stable Following Radiation |
|
San Francisco, CA USA |
|
04/27/2008 |
|
|
|
|
|
Details |
|
Phase II Single Arm Trial of VEGF Trap in Patients With Recurrent Temozolomide-Resistant Malignant Gliomas |
|
Los Angeles, CA USA |
|
04/15/2008 |
|
|
|
Details |
|
Phase II Single Arm Trial of VEGF Trap in Patients With Recurrent Temozolomide-Resistant Malignant Gliomas |
|
San Francisco, CA USA |
|
04/15/2008 |
|
|
|
|
|
Details |
|
Phase I and II, Open-Label, Multi-Center Trials of Pazopanib in Combination with Lapatinib in Adult Patients with Relapsed Malignant Glioma |
|
Los Angeles, CA USA |
|
04/15/2008 |
|
|
|
Details |
|
Phase I and II, Open-Label, Multi-Center Trials of Pazopanib in Combination with Lapatinib in Adult Patients with Relapsed Malignant Glioma |
|
San Francisco, CA USA |
|
04/15/2008 |
|
|
|
|
|
Details |
|
Phase I/II Studies of BAY 43-9006 (Sorafenib) in Combination With OSI-774 (Erlotinib), R115777 (Tipifarnib) or CCI-779 (Temsirolimus) in Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma |
|
Los Angeles, CA USA |
|
04/15/2008 |
|
|
|
Details |
|
A Phase I Study of Vorinostat [Suberoylanilide Hydroxamic Acid (SAHA)] in Combination with Temozolomide in Patients with Malignant Gliomas |
|
Los Angeles, CA USA |
|
04/15/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Loma Linda, CA USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Sacramento, CA USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Pomona, CA USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Sacramento, CA USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme |
|
Sacramento, CA USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase I/II Study of GP96 Heat Shock Protein-Peptide Complex Vaccine in Patients With Recurrent or Progressive High-Grade Glioma |
|
San Francisco, CA USA |
|
03/02/2008 |
|
|
|
|
|
Details |
|
Phase ll Trial of Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Patients With Atypical or Malignant, Primary or Metastatic Brain Tumors of the Central Nervous System |
|
Los Angeles, CA USA |
|
03/02/2008 |
|
|
|
Details |
|
A Phase l Trial of Tumor Associated Antigen Pulsed Dendritic Cell Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma |
|
Los Angeles, CA USA |
|
03/02/2008 |
|
|
|
|
|
Details |
|
Phase I Dose Escalation Study of Autologous Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Malignant Gliomas in Pediatric Patients |
|
Los Angeles, CA USA |
|
03/02/2008 |
|
|
|
Details |
|
Phase I Study of Glioma-Associated Antigen (GAA) Peptide-Pulsed Dendritic Cell Vaccination in Malignant Glioma Patients |
|
Los Angeles, CA USA |
|
03/02/2008 |
|
|
|
|
|
Details |
|
A Phase l Trial of Surgical Resection With Gliadel Wafer Placement Followed by Vaccination With Dendritic Cells Pulsed With Tumor Lysate for Patients With Malignant Glioma
|
|
Los Angeles, CA USA |
|
03/02/2008 |
|
|
|
Details |
|
Phase I Study of Immunization With Autologous Tumor Lysate-Pulsed Dendritic Cells in Patients With Malignant Gliomas (Vaccine Therapy in Treating Patients With Malignant Glioma) |
|
Los Angeles, CA USA |
|
03/02/2008 |
|
|
|
|
|
Details |
|
NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303 |
|
La Jolla, CA USA |
|
03/01/2008 |
|
|
|
Details |
|
NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303 |
|
Sacramento, CA USA |
|
03/01/2008 |
|
|
|
|
|
Details |
|
NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303 |
|
Palo Alto, CA USA |
|
03/01/2008 |
|
|
|
Details |
|
Phase II Study Of 7 Days On/7 Days Off Temozolomide In Patients With High-Grade Glioma |
|
San Francisco, CA USA |
|
01/17/2008 |
|
|
|
|
|
Details |
|
Gliogene: Brain Tumor Linkage Study |
|
San Francisco, CA USA |
|
01/17/2008 |
|
|
|
Details |
|
Phase 1/2 Study of Enzastaurin plus Temozolomide
During and Following Radiation Therapy in Patients with
Newly Diagnosed Glioblastoma Multiforme or
Gliosarcoma |
|
San Francisco, CA USA |
|
10/03/2007 |
|
|
|
|
|
Details |
|
Phase I/II Studies of BAY 43-9006 (sorafenib) in Combination with OSI-774 (erlotinib), R115777 (tipifarnib) or CCI-779 (temsirolimus) in Patients with Recurrent Glioblastoma Multiforme or Gliosarcoma. |
|
San Francisco, CA USA |
|
10/03/2007 |
|
|
|
Details |
|
PHASE-2 STUDY OF TARCEVA IN PATIENTS WITH RECURRENT EGFR POSITIVE AND PTEN WILD TYPE GLIOBLASTOMA MULTIFORME AND GLIOSARCOMA |
|
San Francisco, CA USA |
|
10/03/2007 |
|
|
|
|
|
Details |
|
A Phase II study of Bevacizumab plus Temodar and Tarceva after Radiation Therapy and Temodar in patients with newly diagnosed Glioblastoma or Gliosarcoma who are stable following radiation |
|
San Francisco, CA USA |
|
10/03/2007 |
|
|
|
Details |
|
Phase I/II trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine For Patients With Recurrent High Grade Glioma |
|
San Francisco, CA USA |
|
10/03/2007 |
|
|
|
|
|
Details |
|
NABTC 04-03: A Phase I Study of Vorinostat (Suberolyanilide Hydroxamic Acid [SAHA]) in Combination with Temozolomide in Patients with Malignant Gliomas |
|
San Francisco, CA USA |
|
10/03/2007 |
|
|
|
Details |
|
NABTC 04-01: Lapatinib in Treating Patients Who Are Undergoing Surgery for Recurrent Progressive Glioblastoma Multiforme or Gliosarcoma |
|
Los Angeles, CA USA |
|
10/03/2007 |
|
|
|
|
|
Details |
|
NABTC 04-02: Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma
|
|
Los Angeles, CA USA |
|
10/03/2007 |
|
|
|
Details |
|
NABTC 04-02: Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma
|
|
San Francisco, CA USA |
|
10/03/2007 |
|
|
|
|
|
Details |
|
A Phase II Study of Temozolomide (temodar) in the Treatment of Adult Patients with
Supratentorial Low Grade Glioma |
|
San Francisco, CA USA |
|
10/03/2007 |
|
|
|
Details |
|
A Pharmacokinetic and Pharmacogenomic Study of Patients With High-Grade Gliomas Receiving Daily Radiation Therapy and Temozolomide |
|
Duarte, CA USA |
|
08/31/2007 |
|
|
|
|
|
Details |
|
A Phase II Pilot Trial of Radiation Therapy With Concurrent and Adjuvant Temozolomide, Tamoxifen and Carboplatin (T2C) in the Treatment of Patients With Primary Central Nervous System Malignant Gliomas |
|
Vista, CA USA |
|
08/20/2007 |
|
|
|
Details |
|
Phase I/II Study of ZD6474 (ZactimaTM) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma |
|
Los Angeles, CA USA |
|
08/19/2007 |
|
|
|
|
|
Details |
|
A Pilot Multicenter Phase I/II Trial of RAD001 in Patients With Recurrent Glioblastoma Multiforme |
|
Los Angeles, CA USA |
|
08/19/2007 |
|
|
|
Details |
|
Phase II Trial of Intralesional Adoptive Cellular Therapy of Glioblastoma With Interleukin-2-Stimulated Lymphocytes |
|
Newport Beach, CA USA |
|
08/19/2007 |
|
|
|
|
|
Details |
|
Gliadel and Dendritic Cell Vaccine for Malignant Glioma |
|
Los Angeles, CA USA |
|
08/18/2007 |
|
|
|
Details |
|
A Phase II Trial of Dendritic Cell Vaccine Pulsed with Tumor Lysate Followed by Temozolomide Upon Recurrence in Patients with Newly Diagnosed Glioblastoma |
|
Los Angeles, CA USA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Improving Quality Of Life For Brain Tumor Patients |
|
Los Angeles, CA USA |
|
08/18/2007 |
|
|
|
Details |
|
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
|
Orange, CA USA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
|
Sacramento, CA USA |
|
08/18/2007 |
|
|
|
Details |
|
A Phase II Open-Label, Multiple-Dose Study of Intracavitary Administered 131I-TM-601 in Adult Patients with Recurrent High-Grade Glioma |
|
Duarte, CA USA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
A Phase II Open-Label, Multiple-Dose Study of Intracavitary Administered 131I-TM-601 in Adult Patients with Recurrent High-Grade Glioma |
|
Duarte, CA USA |
|
08/18/2007 |
|
|
|
Details |
|
A Phase II Open-Label, Multiple-Dose Study of Intracavitary Administered 131I-TM-601 in Adult Patients with Recurrent High-Grade Glioma |
|
Los Angeles, CA USA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Phase I Study Of Pioglitazone And Isotretinoin In Patients With Recurrent Or Progressive Malignant Gliomas |
|
Los Angeles, CA USA |
|
08/18/2007 |
|
|
|
Details |
|
Pilot Study of Bevacizamab in Patients with Recurrent or Progressive Primary Brain Tumors |
|
Los Angeles, CA USA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Phase I study of Gefitinib plus Rapamycin for patients with recurrent malignant glioma. |
|
Los Angeles, CA USA |
|
08/18/2007 |
|
|
|
Details |
|
Phase II Trial of Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Patients with Atypical or Malignant, Primary or Metastatic Brain Tumors of the Central Nervous System |
|
Los Angeles, CA USA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma |
|
Los Angeles, CA USA |
|
08/04/2007 |
|
|
|
Details |
|
A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma |
|
Los Angeles, CA USA |
|
08/04/2007 |
|
|
|
|
|
Details |
|
Open-label, Dose Confirmation and Dosimetry Study of Interstitial 131-I chTNT-1/B mAb (Cotara®) for the Treatment of Recurrent Glioblastoma Multiforme (GBM) |
|
Tustin, CA USA |
|
07/31/2007 |
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Los Angeles, CA USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Long Beach, CA USA |
|
04/29/2007 |
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Sacramento, CA USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Downey, CA USA |
|
04/29/2007 |
|
|
|
Details |
|
A Randomized, Open-Label Phase 3 Study of Temozolomide Added to Whole Brain Radiation Therapy Versus Whole Brain Radiation Therapy Alone for the Treatment of Brain Metastasis From Non-Small Cell Lung Cancer |
|
Los Angeles, CA USA |
|
04/27/2007 |
|
|
|
|
|
Details |
|
RTA 744 in Treating Patients With Recurrent or Refractory Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Anaplastic Mixed Oligoastrocytoma, Glioblastoma Multiforme, or Gliosarcoma |
|
Los Angeles, CA USA |
|
11/21/2006 |
|
|
|
Details |
|
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
|
Los Angeles, CA USA |
|
10/12/2006 |
|
|
|
|
|
Details |
|
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
|
Orange, CA USA |
|
10/12/2006 |
|
|
|
Details |
|
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
|
Oakland, CA USA |
|
10/12/2006 |
|
|
|
|
|
Details |
|
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
|
Madera, CA USA |
|
10/12/2006 |
|
|
|
Details |
|
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
|
Los Angeles, CA USA |
|
10/12/2006 |
|
|
|
|
|
Details |
|
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
|
Orange, CA USA |
|
10/12/2006 |
|
|
|
Details |
|
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
|
Travis Air Force Base, CA USA |
|
10/12/2006 |
|
|
|
|
|
Details |
|
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
|
Los Angeles, CA USA |
|
10/12/2006 |
|
|
|
Details |
|
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
|
Sacramento, CA USA |
|
10/12/2006 |
|
|
|
|
|
Details |
|
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
|
Loma Linda, CA USA |
|
10/12/2006 |
|
|
|
Details |
|
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
|
San Francisco, CA USA |
|
10/12/2006 |
|
|
|
|
|
Details |
|
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
|
Downey, CA USA |
|
10/12/2006 |
|
|
|
Details |
|
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
|
Santa Barbara , CA USA |
|
10/12/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Downey, CA USA |
|
05/30/2006 |
|
|
|
Details |
|
Pilot Randomized Study of Modafinil for Treatment of Fatigue and Neurobehavioral Dysfunction in Patients With Primary Brain Tumors |
|
Los Angeles, CA USA |
|
05/29/2006 |
|
|
|
|
|
Details |
|
Phase II Study of Rituximab, Temozolomide, and Methylprednisolone in Patients With Recurrent Primary CNS Non-Hodgkin`s Lymphoma |
|
Los Angeles, CA USA |
|
05/27/2006 |
|
|
|
Details |
|
PEG-Interferon alfa-2b With or Without Thalidomide in Treating Patients With Recurrent High-Grade Gliomas
|
|
Los Angeles, CA USA |
|
05/04/2006 |
|
|
|
|
|
Details |
|
Phase II Study of Temozolomide in Patients With Supratentorial Low-Grade Glioma |
|
San Francisco, CA USA |
|
05/02/2006 |
|
|
|
Details |
|
Headstart II A Phase II study of two alternative intensive induction chemotherapy followed by consolidation with myeloablative chemotherapy and autologous stem cell rescue with or without
subsequent radiation therapy for children less than 10 yrs of age newly diagnosed with malignant brain tumors |
|
Oakland, CA USA |
|
05/01/2006 |
|
|
|
|
|
Details |
|
"Head Start" chemotherapy protocol for children less than 10 years old with newly diagnosed high grade primary brain tumors with intent to eliminate irradiation and abbreviate total duration of treatment to 6 months with resultant improved cure rate and quality of survival. |
|
Oakland, CA USA |
|
05/01/2006 |
|
|
|
Details |
|
Gamma Knife Radiosurgery for Brain Tumors |
|
La Jolla, CA USA |
|
12/03/2005 |
|
|
|
|
|
Details |
|
A Randomized Phase II Study of Peg-Interferon Alpha-2B (Peg-Intron) Alone or in Combination with Thalidomide in Adults with Recurrent High-Grade Gliomas |
|
Los Angeles, CA USA |
|
11/27/2005 |
|
|
|
Details |
|
Double sequential high dose Thiotepa with autologous stem cell rescue for patients age <60 years with recurrent malignant brain cancer. |
|
Los Angeles, CA USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Pre- and Postoperative Use of ZD1839(Iressa) in Recurrent Glioblastoma, Including Translational Research |
|
Los Angeles, CA USA |
|
11/27/2005 |
|
|
|
Details |
|
Phase I Dose Escalation Study of Autologous Antigen-Pulsed Dendritic Cell Immunotherapy for Malignant Gliomas (e.g. Glioblastoma Multiforme, Anaplastic Astrocytoma) |
|
Los Angeles, CA USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Phase I Dose Escalation Study of Autologous Antigen-Pulsed Dendritic Cell Immunotherapy for Malignant Gliomas (e.g. Glioblastoma Multiforme, Anaplastic Astrocytoma) |
|
Los Angeles, CA USA |
|
11/27/2005 |
|
|
|
Details |
|
Tipifarnib and Radiation Therapy in Treating Young Patients with Brainstem Glioma |
|
San Francisco, CA USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Temozolomide in Treating Patients With Progressive Low-Grade Glioma
|
|
San Francisco, CA USA |
|
11/27/2005 |
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Los Angeles, CA USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Orange, CA USA |
|
11/27/2005 |
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
San Diego, CA USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Oakland, CA USA |
|
11/27/2005 |
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Madera, CA USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Los Angeles, CA USA |
|
11/27/2005 |
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Orange, CA USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Travis Air Force Base, CA USA |
|
11/27/2005 |
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Long Beach, CA USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Sacramento, CA USA |
|
11/27/2005 |
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Santa Clara, CA USA |
|
11/27/2005 |
|
|
|
|
